Implementation of liquid chromatography/mass spectrometry into the clinical laboratory

Clinica Chimica Acta

Volumn 420, Issue , 2013, Pages 4-10

  Wu, Alan H B ^a   French, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunoassay; Liquid chromatography; Mass spectrometry; Sensitivity; Specificity

Indexed keywords

25 HYDROXYVITAMIN D; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CALCIFEDIOL; CYCLOBENZAPRINE; CYCLOSPORIN; DOXEPIN; EPITESTOSTERONE; ESTRADIOL; FENTANYL; HEPCIDIN; HYDROXYPROGESTERONE; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; LIOTHYRONINE; MYCOPHENOLIC ACID; PRASTERONE; RAPAMYCIN; STEROID; TACROLIMUS; TESTOSTERONE; THYROID HORMONE; THYROXINE; UNINDEXED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN;

ANALYTICAL EQUIPMENT; ANALYZER; CLINICAL LABORATORY; CONGENITAL ADRENAL HYPERPLASIA; COST; DRUG ABUSE; DRUG METABOLISM; DRUG MONITORING; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUILIBRIUM DIALYSIS; FOOD AND DRUG ADMINISTRATION; FORENSIC TOXICOLOGY; GOVERNMENT REGULATION; HUMAN; IMMUNOASSAY; INBORN ERROR OF METABOLISM; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NEWBORN SCREENING; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION;

CHEMISTRY, CLINICAL; CHROMATOGRAPHY, LIQUID; HUMANS; LIMIT OF DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84877633444     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.026     Document Type: Review

References (51)

1. Grebe S.K.G., Singh R.J. LC-MS/MS in the clinical laboratory - where to from here?. Clin Biochem Rev 2011, 32:5-31.
2. Clinical Laboratory Improvement Amendments (CLIA), . http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html?redirect=/CLIA/.
3. US Food and Drug Administration, . http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCLIA/search.cfm.
4. FDA plans to regulate laboratory developed tests; many questions remain as to details of regulatory scheme, . http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2010/07/fda-plans-to-regulate-laboratory-developed-tests-many-questions-remain-as-to-details-of-regulatory-s.html.
5. England B.G., Parsons G.H., Possley R.M., McConnell D.S., Midgley A.R. Ultrasensitivie semiautomated chemiluminescent immunoassay for estradiol. Clin Chem 2002, 48:1584-1586.
6. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999, 45:942-956.
7. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 2003, 49:1041-1044.
8. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030.
9. Wu A.H.B., Gerona R., Armenian P., French D., Petrie M., Lynch K.L. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol 2012, 50:733-742.
10. Phinney K.W., Bedner M., Tai S.S., et al. Development and certification of a standard reference material for vitamin D metabolites in human serum. Anal Chem 2012, 84:956-962.
11. Vesper H.W., Botelho J.C. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol 2010, 121:513-519.
12. Centers for Disease Control, Prevention Laboratory quality assurance and standardization programs Last accessed 8/29/12. http://www.cdc.gov/labstandards/hs_standardization.html.
13. Taieb J., Mathian B., Millot F., et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clin Chem 2003, 49:1381-1395.
14. Wang C., Catlin D.H., Demers L.M., Starcevic B., Swerdloff R.S. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004, 89:534-543.
15. Rahhal S.N., Fuqua J.S., Lee P.A. The impact of assay sensitivity in the assessment of diseases and disorders in children. Steroids 2008, 73:1322-1327.
16. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Utility, limitations and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007, 92:405-413.
17. Kushnir M.M., Blamires T., Rockwood A.L., et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference ranges. Clin Chem 2010, 56:1138-1147.
18. Wang C., Shiraishi S., Leung A., et al. Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods. Steroids 2008, 73:1345-1352.
19. Salameh W.A., Redor-Goldman M.M., Clarke N.J., Reitz R.E., Caulfield M.P. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges. Steroids 2010, 75:169-175.
20. Yang D.T., Owen W.E., Ramsay C.S., Xie H., Roberts W.L. Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol 2004, 122:332-337.
21. Cao Z., Swift T.A., West C.A., Rosano T.G., Rej R. Immunoassay of estradiol: unanticipated suppression by unconjugated estriol. Clin Chem 2004, 50:160-165.
22. Kushnir M.M., Rockwood A.L., Berquist J., et al. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol 2008, 129:530-539.
23. Guo T., Gu J., Soldin O.P., Singh R.J., Soldin S.J. Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin Biochem 2008, 41:736-741.
24. French D., Gorgi A.W., Ku Ihenetu, Weeks M.A., Lynch K.L., Wu A.H. Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay. Clin Chim Acta 2011, 412:258-262.
25. Singh R.J. Quantitation of 25-OH-vitamin D (25OHD) using liquid chromatography tandem mass spectrometry (LC-MS-MS). Methods Mol Biol 2010, 603:509-517.
26. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91:3055-3061.
27. Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D3 is present in adult serum. J Clin Endocrinol Metab 2012, 97:163-168.
28. Strathmann F.G., Sadilkova K., Laha T.J., et al. 3-Epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta 2012, 413:203-206.
29. Farrell C.J.L., Martin S., McWhinney B., Straub I., Williams P., Hermann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012, 58:531-542.
30. Moon H.-W., Cho J.-H., Hur M., et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 2012, 45:326-330.
31. Hejiboer A.C., Blankenstein M.A., Kema I.P., Buijs M.M. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012, 58:543-548.
32. Wang R., Nelson J.C., Weiss R.M., Wilcox R.B. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 2000, 10:31-39.
33. Glinoer D. Maternal thyroid function in pregnancy. J Endocrinol Invest 1993, 16:374-378.
34. Christofides N.D., Sheehan C.P., Midgley J.E. One-step, labeled-antibody assay for measuring free thyroxin. I. Assay development and validation. Clin Chem 1992, 38:11-18.
35. Després N., Grant A.M. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 1998, 44:440-454.
36. Van Deventer H.E., Mendu D.R., Remaley A.T., Soldin S.J. Inverse long-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry. Clin Chem 2011, 57:122-127.
37. Gu L., Soldin O.P., Soldin S.J. Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem 2007, 40:1386-1391.
38. Yue B., Rockwood A.L., Sandrock T., La'ula S.L., Kushnir M.M., Meikle A.W. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction-liquid chromatography/tandem mass spectrometry. Clin Chem 2008, 54:642-651.
39. Kahric-Janicic N., Soldin S.J., Soldin O.P., West T., Gu J., Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 2007, 17:303-311.
40. Van Houcke S.K., Van Uytfanghe K., Shimizu E., Tani W., Umemoto M., Thienpont L.M. International Federation of Clinical Chemistry and Laboratory Medicine Working Group for the Standardization of Thyroid Function Tests. IFCC International conventional reference procedure for the measurement of free thyroxine in serum: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group for Standardization of Thyroid Function Tests (WG-STFT). Clin Chem Lab Med 2011, 49:1275-1281.
41. Steele B.W., Wang E., Klee G.G., et al. Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med 2005, 129:310-317.
42. Thienpont L.M., Van Uytfanghe K., Beastall G., et al. IFCC Working Group on Standardization of Thyroid Function Tests. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine. Clin Chem 2010, 56:912-920.
43. Ghoshal A.K., Soldin S.J. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS. Clin Biochem 2002, 35:389-392.
44. Buchward A., Winkler K., Epting T. Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. BMC Clin Pharmacol 2012, 12.
45. Schmid R.W., Lotz J., Schweigert R., et al. Multi-site analytical evaluation of a chemilimescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott Architect analyzer. Clin Biochem 2009, 42:1543-1548.
46. Schutz E., Svinarov D., Shipkova M., et al. Cyclosproine whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 1998, 44:2158-2164.
47. Zytkovicz T.H., Fitzgerald E.F., Marsden D., et al. Tandem Mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots. A two-year summary from the New England Newborn Screening Program. Clin Chem 2001, 47:1945-1955.
48. Torresani T., Biason-Lauber A. Congenital adrenal hyperplasia: diagnostic advances. J Inherit Metab Dis 2007, 30:563-575.
49. Kroot J.J.C., Laarakkers C.M.M., Geurts-Moespot A.J., et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010, 56:1570-1579.
50. Reyes H., Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000, 32:94-106.
51. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann Hepatol 2002, 1:20-28.